Related Experiment Video
Updated: Nov 27, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Stability of tuberous sclerosis complex 2 is controlled by methylation at R1457 and R1459
Seishu Gen1, Yu Matsumoto1, Ken-Ichi Kobayashi1
1Laboratory of Nutritional Biochemistry, Department of Agricultural Chemistry, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan.
Abstract:
Mutations in genes that encode components of tuberous sclerosis complex 2 (TSC2) are associated with tuberous sclerosis complex disease. TSC2 interacts with tuberous sclerosis complex 1 to form a complex that negatively regulates cell growth and proliferation via the inactivation of mechanistic target of rapamycin complex 1. The activity of TSC2 is mainly regulated via posttranslational modifications such as phosphorylation. However, the control of TSC2 activity is not entirely achieved by phosphorylation. In this study, we show that TSC2 is methylated at R1457 and R1459 by protein arginine methyltransferase 1 (PRMT1). Methylation of these two residues can affect the phosphorylation status through protein kinase B (Akt) of TSC2 at T1462 and is essential for TSC2 stability. Taken together, these findings indicate that novel posttranslational modifications are important for the regulation of TSC2 stability through PRMT1-mediated methylation.
Insights
Tuberous sclerosis complex 2 (TSC2) stability is regulated by novel methylation. Protein arginine methyltransferase 1 (PRMT1) methylates TSC2, impacting its phosphorylation and stability, crucial for cell growth regulation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Tuberous sclerosis complex 2 (TSC2) mutations cause tuberous sclerosis complex disease.
- TSC2 forms a complex with TSC1 to inhibit cell growth by inactivating mTORC1.
- TSC2 activity is primarily regulated by phosphorylation, but other mechanisms exist.
Purpose of the Study:
- To investigate novel posttranslational modifications regulating TSC2.
- To identify the specific methylation sites and the enzyme responsible for TSC2 methylation.
- To determine the functional impact of TSC2 methylation on its stability and activity.
Main Methods:
- Mass spectrometry to identify methylation sites.
- Site-directed mutagenesis to alter specific arginine residues.
- Western blotting to assess protein levels and phosphorylation status.
- Co-immunoprecipitation assays to study protein interactions.
Main Results:
- TSC2 is methylated at arginine residues R1457 and R1459 by PRMT1.
- PRMT1-mediated methylation affects TSC2 phosphorylation at T1462 by Akt.
- Methylation at R1457 and R1459 is essential for TSC2 protein stability.
- This methylation pathway influences the TSC2-TSC1 complex activity.
Conclusions:
- PRMT1-mediated methylation represents a novel regulatory mechanism for TSC2.
- Methylation is critical for maintaining TSC2 stability and proper cellular function.
- These findings reveal a new layer of posttranslational control over the TSC2 pathway, impacting tuberous sclerosis complex disease.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:54Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
Published on: November 5, 2020
Related Concept Videos
Microtubule Instability
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...